Skip to main content
U.S. Department of Health and Human Services
—
National Institutes of Health
Create Account
Login
Main menu
Discover
Share
Create
Learn
Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4
Autogenerated by
for
Nuclear Juicer
Created on Tue, 2022-07-05 22:09, last updated on Tue, 2022-07-05 22:16
I Printed This
Remix It
Vertical Tabs
General Information
This Model was autogenerated from the
"Quick Submit"
tool.
Model ID
3DPX-017357
Category
Proteins, Macromolecules and Viruses
Keyword(s)
beta-sandwich, immunoglobulin-like fold, TIG domain, IPT domain, Structural Genomics, NPPSFA, National Project on Protein Structural and Functional Analyses, RIKEN Structural Genomics/Proteomics Initiative, RSGI, IMMUNE SYSTEM
Protein Data Bank ID
2YRP
Experimental Method
SOLUTION NMR
Model Details
Oligomeric Details
monomeric
Attribution
Citation Title
Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4
Journal
To be Published
STL/VRML Files
PDB-2YRP-ribbon-secondary.wrl
PDB-2YRP-ribbon-rainbow.wrl
PDB-2YRP-ribbon-bychain.wrl
PDB-2YRP-ribbon.stl
PDB-2YRP-surf-bychain.wrl
PDB-2YRP-surf-hydropathy.wrl
PDB-2YRP-surf-coulombic.wrl
PDB-2YRP-surf.stl
PDB-2YRP.zip
X3D Files
PDB-2YRP-ribbon-secondary.x3d
PDB-2YRP-ribbon-rainbow.x3d
PDB-2YRP-ribbon-bychain.x3d
PDB-2YRP-ribbon.x3d
PDB-2YRP-surf-bychain.x3d
PDB-2YRP-surf-hydropathy.x3d
PDB-2YRP-surf-coulombic.x3d
PDB-2YRP-surf.x3d
Rating
Select rating
Give Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4 1/5
Give Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4 2/5
Give Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4 3/5
Give Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4 4/5
Give Solution structure of the TIG domain from Human Nuclear factor of activated T-cells, cytoplasmic 4 5/5
Cancel rating
No votes yet
Licensing
Comments
0